BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7224812)

  • 21. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Breast cancer recurrences and metastases].
    Bazhenova AP; Kachanov IP
    Khirurgiia (Mosk); 1980 Apr; (4):7-12. PubMed ID: 7374084
    [No Abstract]   [Full Text] [Related]  

  • 23. [Carrying out of surgical and radiologic therapy in relation to tumor type and spreading state in breast cancer].
    von Fournier D; Kubli F; zum Winkel K; Bauer M; Kuttig H
    Strahlentherapie Sonderb; 1981; 76():307-12. PubMed ID: 7303116
    [No Abstract]   [Full Text] [Related]  

  • 24. Update of adjuvant therapy for malignant melanoma and carcinoma of the breast: whom do you believe?
    Humphrey LJ
    Am Surg; 1980 Jan; 46(1):20-3. PubMed ID: 7362145
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patient].
    Besse B; Soria JC
    Rev Prat; 2007 Feb; 57(4):429-40; quiz 440. PubMed ID: 17455746
    [No Abstract]   [Full Text] [Related]  

  • 26. Improvement in the prognosis of Japanese breast cancer patients from 1946 to 2001--an institutional review.
    Yoshimoto M; Tada K; Hori H; Morota A; Tanabe M; Nishimura S; Takahashi K; Makita M; Iwase T; Kasumi F; Takahashi S; Ito Y; Oguchi M; Yamashita T; Akiyama F; Sakamoto G
    Jpn J Clin Oncol; 2004 Aug; 34(8):457-62. PubMed ID: 15371463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of radiation therapy on the use of primary ("neoadjuvant") systemic treatment of breast cancer].
    Souchon R; Dunst J; Hartmann KA
    Strahlenther Onkol; 2006 Apr; 182(4):202-9. PubMed ID: 16622621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locally advanced breast cancer: integration of multimodal concepts.
    Singletary SE
    R I Med; 1995 Sep; 78(9):254-6. PubMed ID: 7579721
    [No Abstract]   [Full Text] [Related]  

  • 29. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast.
    Taylor ME; Haffty BG; Rabinovitch R; Arthur DW; Halberg FE; Strom EA; White JR; Cobleigh MA; Edge SB
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):997-1002. PubMed ID: 19251087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Errors in the treatment of breast cancer].
    Demidov VP; Pak DD; Ostrovtsev LD
    Khirurgiia (Mosk); 1990 Apr; (4):90-5. PubMed ID: 2374366
    [No Abstract]   [Full Text] [Related]  

  • 31. National breast cancer audit: overview of invasive breast cancer management.
    Cuncins-Hearn AV; Boult M; Babidge W; Zorbas H; Villanueva E; Evans A; Oliver D; Kollias J; Reeve T; Maddern G
    ANZ J Surg; 2006 Aug; 76(8):745-50. PubMed ID: 16916399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease.
    Aksu G; Kucucuk S; Fayda M; Saynak M; Baskaya S; Saip P; Ozturk N; Aslay I
    Eur J Surg Oncol; 2007 Apr; 33(3):285-93. PubMed ID: 17145158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast-conserving therapy (BCT) for early-stage breast cancer.
    Benda RK; Mendenhall NP; Lind DS; Cendan JC; Shea BF; Richardson LC; Copeland EM
    J Surg Oncol; 2004 Jan; 85(1):14-27. PubMed ID: 14696083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer. Better treatments save more lives.
    Lewis C
    FDA Consum; 1999; 33(4):7-11. PubMed ID: 10443175
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effective treatment strategy in elderly breast cancer patients].
    Boér K
    Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 37. Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast.
    Gutman H; Pollock RE; Janjan NA; Johnston DA
    J Am Coll Surg; 1995 Feb; 180(2):193-9. PubMed ID: 7850054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
    Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and therapy of breast carcinoma--an interdisciplinary challenge].
    Bender HG
    Praxis (Bern 1994); 1998 Apr; 87(15):524-8. PubMed ID: 9608249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic options for occult breast cancer: a survey of the American Society of Breast Surgeons and review of the literature.
    Khandelwal AK; Garguilo GA
    Am J Surg; 2005 Oct; 190(4):609-13. PubMed ID: 16164933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.